Parkinson's disease: a review from pathophysiology to treatment

BLB Marino, LR de Souza, KPA Sousa… - Mini reviews in …, 2020 - benthamdirect.com
Parkinson's Disease (PD) is the second most common neurodegenerative disease in the
elderly population, with a higher prevalence in men, independent of race and social class; it …

[HTML][HTML] Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management

DZ Mohamed, MES Ghoneim… - World journal of …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered the
causative pathogen of coronavirus disease 2019 (COVID-19) and has become an …

Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop—The Modulating Role of Anacyclus pyrethrum

A Baslam, H Azraida, R Aboufatima, M Ait-El-Mokhtar… - Antioxidants, 2023 - mdpi.com
Trihexyphenidyl (THP)—a synthetic anticholinergic medication used to manage
parkinsonism and extrapyramidal symptoms—has gained significant clinical recognition …

Dystonia

CD Stephen, K Simonyan, L Ozelius… - Neurobiology of Brain …, 2023 - Elsevier
Dystonia is a common movement disorder involving abnormal, often twisting postures and is
a challenging condition to diagnose as we present here in a comprehensive overview. The …

The dystonia coalition: a multicenter network for clinical and translational studies

G Kilic-Berkmen, LJ Wright, JS Perlmutter… - Frontiers in …, 2021 - frontiersin.org
Dystonia is a movement disorder characterized by sustained or intermittent muscle
contractions causing abnormal postures, repetitive movements, or both. Research in …

A novel reduced graphene oxide modified carbon paste electrode for potentiometric determination of trihexyphenidyl hydrochloride in pharmaceutical and biological …

J Radić, M Buljac, B Genorio, E Gričar, M Kolar - Sensors, 2021 - mdpi.com
A novel promising carbon paste electrode with excellent potentiometric properties was
prepared for the analysis of trihexyphenidyl hydrochloride (THP), the acetylcholine receptor …

SPARSE: a sparse hypergraph neural network for learning multiple types of latent combinations to accurately predict drug–drug interactions

DA Nguyen, CH Nguyen, P Petschner… - …, 2022 - academic.oup.com
Motivation Predicting side effects of drug–drug interactions (DDIs) is an important task in
pharmacology. The state-of-the-art methods for DDI prediction use hypergraph neural …

The neurobiological basis for novel experimental therapeutics in dystonia

AM Downs, KM Roman, SA Campbell, A Pisani… - Neurobiology of …, 2019 - Elsevier
Dystonia is a movement disorder characterized by involuntary muscle contractions, twisting
movements, and abnormal postures that may affect one or multiple body regions. Dystonia is …

Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy

MS Moehle, AM Bender, JW Dickerson… - ACS Pharmacology & …, 2021 - ACS Publications
Nonselective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly
inhibit all five mAChR subtypes provide an efficacious treatment for some movement …

Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment

S Musco, V McAllister, I Caudle - Therapeutic Advances in …, 2020 - journals.sagepub.com
Dopamine-receptor blocking agent-associated akathisia (DRBA-A) is an adverse effect that
can significantly limit the use of these important medications for the treatment of a variety of …